Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms (vol 1854, pg 1078, 2015)

Por: Hole M, Underhaug J, Diez H, Ying M, Røhr ÅK, Jorge-Finnigan A, Fernandez-Castillo N, Garcia-Cazorla A, Kristoffer Andersson K, Teigen K and Martinez A

---

Publicada: 1 mar 2016

---

---

Filiaciones:
Hole M:
 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway

Underhaug J:
 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway

Diez H:
 Department of Neurology, Hospital Sant Joan de Déu (HSJD), Barcelona, Spain

 Laboratory of Synaptic Metabolic Diseases, Fundació Sant Joan de Déu (HSJD), Barcelona, Spain

Ying M:
 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway

Røhr ÅK:
 Department of Biosciences, University of Oslo, Oslo, Norway

Jorge-Finnigan A:
 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway

Fernandez-Castillo N:
 Departament de Genètica, Facultat de Biologia, Universitat de Barcelona, and Institut de Biomedicina de la Universitat de Barcelona (IBUB), Spain

 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain

Garcia-Cazorla A:
 Department of Neurology, Hospital Sant Joan de Déu (HSJD), Barcelona, Spain

 Laboratory of Synaptic Metabolic Diseases, Fundació Sant Joan de Déu (HSJD), Barcelona, Spain

 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain

Kristoffer Andersson K:
 Department of Biosciences, University of Oslo, Oslo, Norway

Teigen K:
 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway

Martinez A:
 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway